An initial clue supporting this hypothesis was provided by immunohistochemical (IHC) analyses of tumor sections; the abundance of CD33+ MDSCs was correlated to the level of LMP1 and glucose transporter 1 (GLUT1) expression in malignant epithelial cells. Here, CD33 is linked to neoplasm.